ArticleSisli Etfal Hastanesi tip bulteni2026
The Burden of Stigma in Type 2 Diabetes: Evidence from a Rural Primary Care Sample in Türkiye.
Article in Sisli Etfal Hastanesi tip bulteni, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate the presence of diabetes-related stigma and its relationship with disease control and family functioning among adults with type 2 diabetes mellitus (T2DM) living in rural Türkiye. A cross-sectional study was conducted between March and May 2025 at a Family Health Center (FHC). A total of 201 adults with physician-diagnosed T2DM participated in the study. Methods: Data were collected through face-to-face interviews using a sociodemographic questionnaire, the Diabetes Stigma Assessment Scale-2 (DSAS-2), and the Family APGAR scale, which assesses family functioning. Statistical analyses included correlation tests, group comparisons, and logistic regression to identify independent predictors of stigma. Results: The mean total DSAS-2 score was 39.4±9.2, indicating a moderate level of perceived stigma. Higher stigma scores were associated with very low income, polypharmacy, and the presence of comorbid chronic diseases (p<0.05). A positive correlation was found between the number of children and both the "Treated Differently" and "Self-Stigma" subdimensions of the DSAS-2 (r=0.202 and r=0.216, respectively). Family APGAR scores were generally high (mean=8.9±2.0), but no significant association was observed between family functioning and stigma levels. Logistic regression analysis showed that medication use was independently associated with higher stigma (OR: 2.48; 95% CI: 1.23-4.98; p=0.011), whereas moderate income was associated with lower stigma (OR: 0.165; 95% CI: 0.048-0.567; p=0.004). Conclusion: Diabetes-related stigma remains a notable psychosocial challenge for adults with T2DM in rural settings. Socioeconomic disadvantage, comorbidity, and family burden contribute to the internalization of stigma, whereas family support alone may not mitigate its effects. Addressing stigma within primary care through culturally tailored psychoeducation and empowerment programs may enhance both emotional well-being and disease management in rural populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.